Compare · 3 funds side by side · dividends reinvested

BBC, XLV and VOO

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$18,115VOO · best of the three

02 / 04

BBC, XLV and VOO, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard S&P 500 ETFLow-Cost Core · S&P 5000.03%1.05%+13.4%+13.5%+24.2%+12.6%−8.9%12.8%$1.00T1.8

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.34%+24.0%+33.5%+17.2%+9.4%−10.5%16.6%$49.1B2.0

Virtus Biotech Clinical Trials ETFSectors · Health care0.65%1.50%+13.1%+43.3%+37.4%+0.6%−30.2%37.6%$34M2.3

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 4, 2026 · returns include dividends · since: BBC 2014 · XLV 1998 · VOO 2010

Head to Head

Swap sides Versus in desk

Head to Head

Virtus Biotech Clinical Trials ETF · $34M$10,290

BBC

XLV

State Street Health Care Select Sector SPDR ETF · $49.1B$15,652

$10,000 five years ago, dividends reinvested · they hold 0.0% in common

BBCMeasureXLV

+13.1%Year to dateJan 1 → Nov 4+24.0%

+43.3%1 yearTotal return+33.5%

+37.4%3 years · per year$10,000 became $25,933 · $16,102+17.2%

+0.6%5 years · per year$10,000 became $10,290 · $15,652+9.4%

0.65%Expense ratio$65 · $8 a year on $10k · lower is better0.08%

1.50%Trailing 12-mo yield$150 · $134 a year on $10k1.34%

−30.2%Worst dropSmaller is better−10.5%

37.6%VolatilityLower is calmer16.6%

BBCXLV Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5XLV wins

End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

BBC vs XLV: Top 5 Holdings

Today

BBC

9.9%in top 5

XLV

in top 544.9%

BBCStockXLV

not top 5LLY16.9%

not top 5JNJ9.6%

not top 5ABBV7.6%

not top 5UNH5.4%

not top 5MRK5.3%

2.3%KODnot top 5

2.0%TRAXnot top 5

1.9%XNCRnot top 5

1.8%REPLnot top 5

1.8%ABCLnot top 5

Held in common0.0%

End-of-day Nov 4, 2026 · share of each fund

BBC vs XLV Returns, Every Period

VirtusBBC

+0.6%

5 years, per year

XLVSPDR

+9.4%

5 years, per year

BBCXLVFaded: behind in that period

2–2Level

End-of-day Nov 4, 2026 · dividends in · faded = behind in that period

BBC vs XLV

YTD

VirtusBBC

+13.1%

XLVSPDR

+24.0%

+13.1%Year to date+24.0%

−30.2%Worst drop · 1Y−10.5%

37.6%Volatility · 1Y16.6%

1.5%Yield1.3%

$34.3MAssets$49.1B

3–1XLV wins

End-of-day Nov 4, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: BBC, XLV, VOO

Today

0.03%lowest, VOO

FundExpense ratioFee$10k

VOO0.03%$3

XLV0.08%$8

BBC0.65%$65

End-of-day Nov 4, 2026 · fee on $10,000 a year

Yields: BBC, XLV, VOO

1.50%highest, BBC

FundTrailing yieldYield$10k

BBC1.50%$150

XLV1.34%$134

VOO1.05%$105

End-of-day Nov 4, 2026 · trailing 12-month yield

Income After Fees on $10,000

$126most kept, XLV

XLV$134 − $8 = $126

VOO$105 − $3 = $102

BBC$150 − $65 = $85

KeptFee

End-of-day Nov 4, 2026 · yield in dollars minus the fee

Overlap: BBC, XLV, VOO

Today

9.3%most shared, XLV and VOO

BBCXLVVOO

BBC—0.0%0.0%

XLV0.0%—9.3%

VOO0.0%9.3%—

End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+43.3%BBC, at 37.6% volatility

VOOWorst drop−8.9%12.8% vol

XLVWorst drop−10.5%16.6% vol

BBCWorst drop−30.2%37.6% vol

End-of-day Nov 4, 2026 · up and left is better

Paid More vs Made More

YTD

BBCXLV

+13.1%Year to date+24.0%

1.5%Yield1.3%

+43.3%Past year+33.5%

0.65%Fee0.08%

2–2level

End-of-day Nov 4, 2026

Popular Pairs Near These Three

SPYM vs SPY

YTD

SPDRSPYM

+13.4%

SPYSPDR

+13.3%

+13.4%Year to date+13.3%

1.0%Yield1.0%

$182BAssets$805B

1–0SPYM wins

End-of-day Nov 4, 2026

VOO vs IVV

YTD

VanguardVOO

+13.4%

IVViShares

+13.4%

+13.4%Year to date+13.4%

1.1%Yield1.1%

$1.00TAssets$887B

0–0level

End-of-day Nov 4, 2026

SCHD vs VIG

YTD

SchwabSCHD

+35.3%

VIGVanguard

+16.4%

+35.3%Year to date+16.4%

2.9%Yield1.4%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 4, 2026